Nikko Asset Management Americas, Inc. 10x Genomics, Inc. Transaction History

Nikko Asset Management Americas, Inc.

$8.64 Billion
Q3 2024

A detailed history of Nikko Asset Management Americas, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 6,373,212 shares of TXG stock, worth $84.9 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares

6,373,212

Previous 6,148,252 3.66%

Holding current value

$84.9 Million

Previous $120 Million 20.34%

% of portfolio

1.67%

Previous 1.4%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$15.71 - $23.49 $3.53 Million - $5.28 Million	224,960 Added 3.66%	6,373,212 $144 Million
Q2 2024 Aug 09, 2024	BUY	$19.45 - $37.37 $49.1 Million - $94.4 Million	2,526,474 Added 69.76%	6,148,252 $120 Million
Q1 2024 May 02, 2024	BUY	$36.08 - $54.3 $48.3 Million - $72.7 Million	1,338,248 Added 58.6%	3,621,778 $136 Million
Q4 2023 Feb 08, 2024	BUY	$34.32 - $57.55 $19.4 Million - $32.5 Million	565,059 Added 32.88%	2,283,530 $128 Million
Q3 2023 Nov 09, 2023	SELL	$40.86 - $62.98 $1.93 Million - $2.97 Million	-47,163 Reduced 2.67%	1,718,471 $70.9 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $13 Million - $15 Million	-255,435 Reduced 12.64%	1,765,634 $98.6 Million
Q1 2023 May 03, 2023	SELL	$35.33 - $55.79 $5.54 Million - $8.75 Million	-156,919 Reduced 7.2%	2,021,069 $113 Million
Q4 2022 Feb 13, 2023	SELL	$24.4 - $41.3 $714,188 - $1.21 Million	-29,270 Reduced 1.33%	2,177,988 $79.4 Million
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $22.6 Million - $41.7 Million	793,419 Added 56.12%	2,207,258 $61.1 Million
Q2 2022 Aug 04, 2022	SELL	$36.95 - $82.41 $662,661 - $1.48 Million	-17,934 Reduced 1.25%	1,413,839 $56.6 Million
Q1 2022 May 06, 2022	BUY	$55.7 - $145.79 $10.2 Million - $26.8 Million	183,813 Added 14.73%	1,431,773 $109 Million
Q4 2021 Feb 08, 2022	SELL	$135.05 - $182.59 $11.6 Million - $15.6 Million	-85,584 Reduced 6.42%	1,247,960 $166 Million
Q3 2021 Nov 09, 2021	SELL	$145.58 - $192.14 $30.3 Million - $40 Million	-208,044 Reduced 13.5%	1,333,544 $192 Million
Q2 2021 Aug 09, 2021	BUY	$134.22 - $202.37 $66.9 Million - $101 Million	498,675 Added 47.82%	1,541,588 $299 Million
Q1 2021 May 03, 2021	BUY	$140.25 - $196.86 $130 Million - $182 Million	924,534 Added 780.99%	1,042,913 $189 Million
Q4 2020 Feb 11, 2021	BUY	$126.47 - $163.7 $2.04 Million - $2.64 Million	16,111 Added 15.75%	118,379 $16.8 Million
Q3 2020 Nov 02, 2020	SELL	$87.44 - $125.0 $9.09 Million - $13 Million	-103,945 Reduced 50.41%	102,268 $12.2 Million
Q2 2020 Aug 07, 2020	BUY	$58.39 - $89.31 $12 Million - $18.4 Million	206,213 New	206,213 $17.8 Million

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.27B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account

Nikko Asset Management Americas, Inc. 10x Genomics, Inc. Transaction History